Ultragenyx price target lowered to $33 from $103 at Cantor Fitzgerald
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Cantor Fitzgerald lowers RARE target to $33 from $103, with current price $14.79; upside to the target remains implied.
Target: $33
Posted price: $14.79
Analyst firm: Cantor Fitzgerald
Analyst: Kristen Kluska
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.